FDA 483 - Scholly Fiberoptic GmbH - September 28, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Scholly Fiberoptic GmbH, a medical device manufacturer in Denzlingen, Germany, was cited for significant deficiencies in its quality system during an FDA inspection. The firm's corrective and preventive action procedures were found ineffective, leading to recurring product issues. Additionally, complaint handling procedures failed to adequately evaluate complaints for Medical Device Reporting, and device history records were incomplete regarding labeling information.
ID · f5f1deea-c260-4995-b008-7f238472f527